+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Gypenoside BP2214

BP2214
862286-47-3
98%
Phytopurify
Gypenoside XVII confers protection against Aβ25-35-induced neurotoxicity through estrogen receptor-dependent activation of PI3K/Akt pathways, inactivation of GSK-3β and activation of Nrf2/ARE/HO-1 pathways. Gypenoside XVII has protective effects to the cellular and rodent models of Alzheimer's disease by activating TFEB.
Catalog No Package Original Price Price Inventory Quantity Operating
BP2214-5mg 5mg
BP2214-10mg 10mg
BP2214-20mg 20mg
BP2214-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

NFE2L2 ESR1 GSK3B PIK3CA AKT1 HMOX1
TP53 AKT1 BRAF NRAS CDKN2A KRAS
NFE2L2 GSK3B PIK3CA AKT1 HMOX1 PINK1

Product drug property prediction parameters

  • 269.8200

  • 3.0023

  • 3.0025

  • .0382

  • .5308

  • .3195

  • Low

  • 76.2861

  • 6.4817

  • No

  • No

  • Yes

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • No